The expression of APRIL in Sjögren's syndrome: Aberrant expression of APRIL in the salivary gland

Rheumatology (United Kingdom)

Volumn 51, Issue 9, 2012, Pages 1557-1562

  Vosters, Jelle L ^a,b   Roescher, Nienke ^a,b   Polling, Eline J ^a   Illei, Gabor G ^b   Tak, Paul P ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

A proliferation inducing ligand; Minor salivary glands; Sj gren's syndrome

Indexed keywords

APRIL PROTEIN; B CELL ACTIVATING FACTOR; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR; BIOLOGICAL MARKER; TNFRSF13B PROTEIN, HUMAN; TNFSF13B PROTEIN, HUMAN;

ADULT; ARTICLE; CONTROLLED STUDY; DESCRIPTIVE RESEARCH; DIGITAL IMAGING; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; MALE; MINOR SALIVA GLAND; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SALIVARY GLAND; SALIVATION; SJOEGREN SYNDROME; IMAGE PROCESSING; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; SALIVA; SECRETION (PROCESS);

B-CELL ACTIVATING FACTOR; BIOLOGICAL MARKERS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; SALIVA; SALIVARY GLANDS, MINOR; SJOGREN'S SYNDROME; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR PROTEIN; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 13;

EID: 84865328225     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kes080     Document Type: Article

References (20)

1. Hansen A, Odendahl M, Reiter K et al. Diminished peripheral blood memory B cells and accumulation of memory B cells in the salivary glands of patients with Sjogren's syndrome. Arthritis Rheum 2002;46:2160-71.
2. Dillon SR, Gross JA, Ansell SM, Novak AJ. An APRIL to remember: novel TNF ligands as therapeutic targets. Nat Rev Drug Discov 2006;5:235-46.
3. Moreaux J, Cremer FW, Reme T et al. The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature. Blood 2005;106:1021-30.
4. Hahne M, Kataoka T, Schroter M et al. APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth. J Exp Med 1998;188:1185-90.
5. Alsaleh G, Messer L, Semaan N et al. BAFF synthesis by rheumatoid synoviocytes is positively controlled by alpha5beta1 integrin stimulation and is negatively regulated by tumor necrosis factor alpha and Toll-like receptor ligands. Arthritis Rheum 2007;56:3202-14.
6. Ittah M, Miceli-Richard C, Gottenberg JE et al. Viruses induce high expression of BAFF by salivary gland epithelial cells through TLR-and type-I IFN-dependent and -independent pathways. Eur J Immunol 2008;38:1058-64.
7. Jonsson MV, Szodoray P, Jellestad S, Jonsson R, Skarstein K. Association between circulating levels of the novel TNF family members APRIL and BAFF and lymphoid organization in primary Sjogren's syndrome. J Clin Immunol 2005;25:189-201.
8. Lombardi T, Moll S, Youinou P et al. Absence of up-regulation for a proliferation-inducing ligand in Sjogren's sialadenitis lesions. Rheumatology 2011;50: 1211-5.
9. Seyler TM, Park YW, Takemura S et al. BLyS and APRIL in rheumatoid arthritis. J Clin Invest 2005;115:3083-92.
10. Stohl W, Metyas S, Tan SM et al. Inverse association between circulating APRIL levels and serological and clinical disease activity in patients with systemic lupus erythematosus. Ann Rheum Dis 2004;63:1096-103.
11. Morel J, Roubille C, Planelles L et al. Serum levels of tumour necrosis factor family members a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BLyS) are inversely correlated in systemic lupus erythematosus. Ann Rheum Dis 2009;68:997-1002.
12. Townsend MJ, Monroe JG, Chan AC. B-cell targeted therapies in human autoimmune diseases: an updated perspective. Immunol Rev 2010;237:264-83.
13. Haringman JJ, Vinkenoog M, Gerlag DM et al. Reliability of computerized image analysis for the evaluation of serial synovial biopsies in randomized controlled trials in rheumatoid arthritis. Arthritis Res Ther 2005;7:R862-7.
14. Vallerskog T, Heimburger M, Gunnarsson I et al. Differential effects on BAFF and APRIL levels in rituximab-treated patients with systemic lupus erythematosus and rheumatoid arthritis. Arthritis Res Ther 2006;8: R167.
15. Tsunawaki S, Nakamura S, Ohyama Y et al. Possible function of salivary gland epithelial cells as nonprofessional antigen-presenting cells in the development of Sjogren's syndrome. J Rheumatol 2002; 29:1884-96.
16. Ittah M, Miceli-Richard C, Eric Gottenberg J et al. B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjogren's syndrome. Arthritis Res Ther 2006;8:R51.
17. Hjelmervik TO, Petersen K, Jonassen I et al. Gene expression profiling of minor salivary glands clearly distinguishes primary Sjogren's syndrome patients from healthy control subjects. Arthritis Rheum 2005;52: 1534-44.
18. Jung DJ, Bong JJ, Baik M. Extracellular proteinase inhibitor-accelerated apoptosis is associated with B cell activating factor in mammary epithelial cells. Exp Cell Res 2004;292:115-22.
19. Alexaki VI, Notas G, Pelekanou V et al. Adipocytes as immune cells: differential expression of TWEAK, BAFF, and APRIL and their receptors (Fn14, BAFF-R, TACI, and BCMA) at different stages of normal and pathological adipose tissue development. J Immunol 2009;183: 5948-56.
20. Lavie F, Miceli-Richard C, Quillard J et al. Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjogren's syndrome. J Pathol 2004;202: 496-502.